Enhancing prostate cancer diagnosis and reducing unnecessary biopsies with [¹⁸F]DCFPyL PET/CT imaging in PI-RADS 3/4 patients.

ABSTRACT: For patients presenting with prostate imaging reporting and data system (PI-RADS) 3/4 findings on magnetic resonance imaging (MRI) examinations, the standard recommendation typically involves undergoing a biopsy for pathological assessment to ascertain the nature of the lesion. This course of action, though essential for accurate diagnosis, invariably amplifies the psychological distress experienced by patients and introduces a host of potential complications associated with the biopsy procedure. However, [¹⁸F]DCFPyL PET/CT imaging emerges as a promising alternative, demonstrating considerable diagnostic efficacy in discerning benign prostate lesions from malignant ones. This study aims to explore the diagnostic value of [¹⁸F]DCFPyL PET/CT imaging for prostate cancer

SUBMITTER: Fu Y 

PROVIDER: S-EPMC11226634 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature